Director, Enterprise Account Management, Life Sciences

Lila Sciences is hiring a Director, Enterprise Account Management, Life Sciences to own our most strategic pharma relationships. You will carry a named portfolio of top 20 pharma accounts and be accountable for the revenue they generate, from multi-year account strategy through negotiation and close.

The platform you are selling is the world's first platform for scientific superintelligence: closed-loop AI and autonomous labs applied to target discovery, small molecule, and biologics. Your buyers are senior and technical, spanning discovery, translational, platform, data and AI, and BD and licensing, with procurement and legal in the loop on every large agreement.

This is a senior individual contributor role. You will not manage a team, but you will set the standard for how Lila engages its largest customers and will shape commercial strategy well beyond your own book, working across product, science, software, and robotics to convert platform capability into signed enterprise contracts.

• Own a named portfolio of top 20 pharma accounts end to end, with direct accountability for revenue
• Build and execute multi-year account strategies covering expansion, whitespace, and renewal
• Establish and maintain executive relationships at the R&D leadership and C-suite level
• Lead complex, multi-quarter pursuits across discovery, translational, platform, data and AI, and BD and licensing stakeholders
• Negotiate and close large enterprise agreements, working with legal, finance, and procurement
• Maintain accurate forecasts and surface tradeoffs, priorities, and risks to Lila's leadership team
• Partner with product and science to scope high-value engagements and unblock technical inputs
• Own technical RFI and DDQ response for strategic accounts, packaging polished customer-facing deliverables
• Shape enterprise commercial strategy, including qualification standards, deal structures, and pricing input
• Translate the AI and life sciences partnership landscape into implications for Lila's positioning

• 10+ years in enterprise sales, business development, or commercial leadership, including ownership of strategic accounts
• Track record closing large, multi-quarter enterprise agreements with top 20 pharma or comparable accounts
• Degree in biology, chemistry, biochemistry, bioengineering, or adjacent fields, or equivalent experience
• Fluency across the pharma R&D value chain, from discovery through early development
• Proven executive presence with R&D leadership and C-suite buyers
• Ability to translate AI and autonomous lab capability into credible scientific and commercial narratives
• Comfortable operating where the category, product, and commercial motion are still being defined
• Hands-on use of AI tools in daily work

• Working familiarity with AI and ML applied to life sciences, including target identification, generative models for molecules and biologics, predictive ADMET, and computational biology
• Direct experience with pharma enterprise R&D buying cycles, including alliance and partnership structures
• Prior experience at a frontier AI, biotech, or platform company selling to technical buyers
• Early GTM or commercial hire experience defining playbooks and deal structures
• A clear point of view on where AI is and is not useful in life sciences R&D today

Lila Sciences is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Information you provide during your application process will be handled in accordance with our Candidate Privacy Policy.

Lila Sciences does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Lila Sciences or its employees is strictly prohibited unless contacted directly by Lila Science’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Lila Sciences, and Lila Sciences will not owe any referral or other fees with respect thereto.